Journal of Human Reproductive Science
Home Ahead of Print Current Issue Archives
   Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size    Users online: 620

    Article Cited by others

ORIGINAL ARTICLE

Effect of bromocriptine on the severity of ovarian hyperstimulation syndrome and outcome in high responders undergoing assisted reproduction

Sherwal Vinita, Malik Sonia, Bhatia Vandana

Year : 2010| Volume: 3| Issue : 2 | Page no: 85-90

   This article has been cited by
 
1 Dopamine receptor 2 activation inhibits ovarian vascular endothelial growth factor secretion in an ovarian hyperstimulation syndrome (OHSS) animal model: implications for treatment of OHSS with dopamine receptor 2 agonists
Hortensia Ferrero,Carmen M. García-Pascual,María Gaytán,Concepción Morales,Carlos Simón,Francisco Gaytán,Antonio Pellicer,Raúl Gómez
Fertility and Sterility. 2014;
[Pubmed]  [Google Scholar] [DOI]
2 Dopamine agonists in prevention of ovarian hyperstimulation syndrome
Miro Kasum,Hrvoje Vrcic,Patrik Stanic,Davor Ježek,Slavko Oreškovic,Lidija Beketic-Oreškovic,Marijeta Pekez
Gynecological Endocrinology. 2014; : 1
[Pubmed]  [Google Scholar] [DOI]
3 Dopamine receptor 2 activation inhibits ovarian vascular endothelial growth factor secretion in vitro: implications for treatment of ovarian hyperstimulation syndrome with dopamine receptor 2 agonists
Hortensia Ferrero,Carmen M. García-Pascual,Raúl Gómez,Francisco Delgado-Rosas,Omar Cauli,Carlos Simón,Francisco Gaytán,Antonio Pellicer
Fertility and Sterility. 2014; 101(5): 1411
[Pubmed]  [Google Scholar] [DOI]
4 Bromocriptine effect in spontaneous motor activity using albino mice
Al-Gdamsi, M.T. and Aburawi, S.M.
Jordan Journal of Pharmaceutical Sciences. 2013; 6(2): 180-187
[Pubmed]  [Google Scholar]
5 Subchronic Oral Bromocriptine Methanesulfonate Enhances Open Field Novelty-Induced Behavior and Spatial Memory in Male Swiss Albino Mice
Olakunle James Onaolapo,Adejoke Yetunde Onaolapo
Neuroscience Journal. 2013; 2013: 1
[Pubmed]  [Google Scholar] [DOI]
6 Do dopamine agonists prevent or reduce the severity of ovarian hyperstimulation syndrome in women undergoing assisted reproduction? A systematic review and meta-analysis
Miriam Baumgarten,Lukasz Polanski,Bruce Campbell,Nick Raine-Fenning
Human Fertility. 2013; 16(3): 168
[Pubmed]  [Google Scholar] [DOI]
7 Etiology of OHSS and use of dopamine agonists
Sérgio Reis Soares
Fertility and Sterility. 2012; 97(3): 517
[Pubmed]  [Google Scholar] [DOI]
8 VEGF antagonist for the prevention of ovarian hyperstimulation syndrome: Current status
Nikita Naredi,Pankaj Talwar,K. Sandeep
Medical Journal Armed Forces India. 2012;
[Pubmed]  [Google Scholar] [DOI]
9 Etiology of OHSS and use of dopamine agonists
Soares, S.R.
Fertility and Sterility. 2012; 97(3): 517-522
[Pubmed]  [Google Scholar]
10 Ovarian hyperstimulation syndrome
Wiwanitkit, V.
Singapore Medical Journal. 2011; 52(5): 381
[Pubmed]  [Google Scholar]

 

Read this article